Rizza R A, Westland R E, Hall L D, Patton G S, Haymond M W, Clemens A H, Gerich J E, Service F J
Mayo Clin Proc. 1981 Jul;56(7):434-8.
The effects of peripheral venous and portal venous delivery of insulin by a closed-loop insulin infusion device (Biostator GCIIS) on postprandial hyperglycemia and rates of glucose appearance, disappearance, and clearance were compared in alloxan-diabetic dogs. The amounts of insulin required and the peripheral venous plasma insulin concentrations achieved were not different for the two routes of insulin administration. No statistically significant differences in postprandial hyperglycemia or patterns of glucose disposal were observed between the two routes of insulin delivery. These studies indicate that in terms of hepatic versus extrahepatic disposal of glucose, there appears to be no practical advantage of portal venous over peripheral venous administration of insulin when a closed-loop insulin infusion device is used.
在四氧嘧啶糖尿病犬中,比较了闭环胰岛素输注装置(Biostator GCIIS)经外周静脉和门静脉输注胰岛素对餐后高血糖以及葡萄糖出现率、消失率和清除率的影响。两种胰岛素给药途径所需的胰岛素量以及外周静脉血浆胰岛素浓度并无差异。两种胰岛素给药途径在餐后高血糖或葡萄糖处置模式方面未观察到统计学上的显著差异。这些研究表明,就肝脏与肝外葡萄糖处置而言,当使用闭环胰岛素输注装置时,门静脉输注胰岛素相对于外周静脉输注胰岛素似乎并无实际优势。